- Navari Family Professor in Life Sciences, University of Notre Dame
- Professor, Wayne State University
- Associate Professor, Wayne State University
- Assistant Professor, Wayne State University
- Postdoctoral Research Associate, Rockefeller University
- Ph.D. in Chemistry, University of Chicago
- B.S. in Chemistry, University of Southern California
- B.S. in Biological Sciences, University of Southern California
- Emil Thomas Kaiser Award
- Fellow, Science Without Borders, Brazil
- Research Achievement Award, University of Notre Dame
- Astellas USA Foundation Award of the American Chemical Society
- Elected Fellow, America Association for the Advancement of Science
- Charles H. Gershenson Distinguished Faculty Fellow
The Mobashery research program integrates computation, biochemistry, molecular biology, and the organic synthesis of medically important molecules. Bringing together these different disciplines is desirable to produce both scientific and medical advances for difficult, but critically important clinical problems.
Bacterial Antibiotic Resistance, Cell Wall and Discovery of Novel Antibiotics
The studies of antibiotics and antibiotic resistance are central themes in the Mobashery laboratory. Mechanisms of resistance to β-lactam antibiotics have been studied, with a focus on methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa as two nefarious human bacterial pathogens. A multidisciplinary approach is taken towards elucidating the distinct strategies that nature has devised to counter the use of antibiotics in the clinic. Significant work has also been directed towards the bacterial cell wall. The cell wall is a structure that encases the entire organism, and it is critically important for its survival. Its complex biosynthesis and recycling are subjects of study. Discovery of novel antibacterials is another large focus of attention.
Diseases of the Extracellular Matrix
The Mobashery laboratory is interested in diseases of the extracellular matrix (ECM). The ECM is an environment that surrounds every cell in higher organisms. There are many proteins and carbohydrates within this environment, whose homeostasis is highly regulated. When these regulatory processes break down, many disparate diseases ensue. The Mobashery lab investigates how these diseases develop and progress, and designs novel therapeutics for their intervention. The diseases of matrix of interest in the Mobashery lab include diabetes, pulmonary fibrosis, traumatic-brain injury and stroke.
- Boudreau, M. A., Ding, D., Meisel, J. E., Janardhanan, J., Spink, E., Peng, Z., Qian, Y., Yamaguchi, T., Testero, S. A., O'Daniel, P. I., Leemans, E., Lastochkin, E., Song, W., Schroeder, V. A., Wolter, W. R., Suckow, M. A., Mobashery, S., Chang, M. "Structure-Activity Relationship for the Oxadiazole Class of Antibacterials" 2020 ACS Medicinal Chemistry Letters, 11 (3), pp. 322-326. DOI:10.1021/acsmedchemlett.9b00379.
- Dik, D. A., Kim, C., Madukoma, C. S., Fisher, J. F., Shrout, J. D., Mobashery, S. "Fluorescence assessment of the ampr-signaling network of pseudomonas aeruginosa to exposure to β-lactam antibiotics" 2020 ACS Chemical Biology, 15 (5), pp. 1184-1194. DOI:10.1021/acschembio.9b00875.
- Min, K., An, D. R., Yoon, H. -., Rana, N., Park, J. S., Kim, J., Lee, M., Hesek, D., Ryu, S., Kim, B. M., Mobashery, S., Suh, S. W., Lee, H. H. "Peptidoglycan reshaping by a noncanonical peptidase for helical cell shape in Campylobacter jejuni" 2020 Nature Communications, 11 (1), 458. DOI:10.1038/s41467-019-13934-4.
- Qian, Y., Allegretta, G., Janardhanan, J., Peng, Z., Mahasenan, K. V., Lastochkin, E., Gozun, M. M. N., Tejera, S., Schroeder, V. A., Wolter, W. R., Feltzer, R., Mobashery, S., Chang, M. "Exploration of the Structural Space in 4(3 H)-Quinazolinone Antibacterials" 2020 Journal of medicinal chemistry, 63 (10), pp. 5287-5296. DOI:10.1021/acs.jmedchem.0c00153.
- Speri, E., Janardhanan, J., Masitas, C., Schroeder, V. A., Lastochkin, E., Wolter, W. R., Fisher, J. F., Mobashery, S., Chang, M. "Discovery of a Potent Picolinamide Antibacterial Active against Clostridioides difficile" 2020 ACS Infectious Diseases, 6 (9), pp. 2362-2368. DOI:10.1021/acsinfecdis.0c00479.
- Wang, T., Hu, Z., Du, X., Shi, Y., Dang, J., Lee, M., Hesek, D., Mobashery, S., Wu, M., Liang, H. "A type VI secretion system delivers a cell wall amidase to target bacterial competitors" 2020 Molecular Microbiology, 114 (2), pp. 308-321. DOI:10.1111/mmi.14513.